v3.26.1
Statements of Changes in Shareholders’ Deficit - USD ($)
$ in Thousands
Common Shares
Additional Paid-in Capital
Accumulated Deficit
Total Shareholders’ Equity (Deficit)
Non-controlling Interests
Total
Balance at Jun. 30, 2024 [1] $ 420,568 $ (420,472) $ 96 $ 5,319 $ 5,415
Balance (in Shares) at Jun. 30, 2024 5,408,212          
Share-based compensation to employees, directors, and non-employee consultants (note 13(2)) [1] 1,982 1,982 161 2,143
Share-based compensation to employees, directors, and non-employee consultants (note 13(2))(in Shares) 342,388          
Issuance of common shares and warrants related to the February 2025 Offering, net of issuance costs of $420 (see note 13(1)b. and 13(1)c.) [1] 3,873 3,873 3,873
Issuance of common shares and warrants related to the February 2025 Offering, net of issuance costs of $420 (see note 13(1)b. and 13(1)c.) (in Shares) 1,167,028          
Common Warrants and Pre-Funded Warrants (defined below) reclassification to equity (see note 13(1)b.) 5,151 5,151 5,151
Issuance of common shares related to the Kokomodo Transaction (defined below), net of issuance costs of $47 (see note 13(1)d.) [1] 4,639 4,639 1,164 5,803
Issuance of common shares related to the Kokomodo Transaction (defined below), net of issuance costs of $47 (see note 13(1)d.) (in Shares) 976,139          
Net loss (22,583) (22,583) (667) (23,250)
Balance at Jun. 30, 2025 [1] 436,213 (443,055) (6,842) 5,977 $ (865)
Balance (in Shares) at Jun. 30, 2025 7,893,767         7,893,767
Share-based compensation to employees, directors, and non-employee consultants (note 13(2)) [1] 2,553 2,553 1,173 $ 3,726
Share-based compensation to employees, directors, and non-employee consultants (note 13(2))(in Shares) 642,075          
Issuance of common shares, the First Common Warrants and the Second Common Warrants related to the First Offering and the Second Offering (each as defined below), net of issuance costs of $6 (see note 13(1)e. and note 13(1)f.) [1] 4,994 4,994 4,994
Issuance of common shares, the First Common Warrants and the Second Common Warrants related to the First Offering and the Second Offering (each as defined below), net of issuance costs of $6 (see note 13(1)e. and note 13(1)f.) (in Shares) 1,250,000          
Issuance of common shares under the Sales Agreement (as defined below) with Alliance Global Partners, or A.G.P., net of issuance costs of $59 (see note 13(1)a.) [1] 80 80 80
Issuance of common shares under the Sales Agreement (as defined below) with Alliance Global Partners, or A.G.P., net of issuance costs of $59 (see note 13(1)a.) (in Shares) 36,300          
Exercise of pre-funded warrants (see note 13(1)b.) [1]
Exercise of pre-funded warrants (see note 13(1)b.) (in Shares) 1,002,169          
Net loss (23,821) (23,821) (1,548) (25,369)
Balance at Jun. 30, 2026 [1] $ 443,840 $ (466,876) $ (23,036) $ 5,602 $ (17,434)
Balance (in Shares) at Jun. 30, 2026 10,824,311         10,824,311
[1] Less than $1